Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Journal of Pharmacology
|
June 26, 2021
PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3
Minghui Wang, Jingyan Li, Yanqing Ding, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 11, 2023
miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway
Sidong Cai, Junlei Chang, Mengqi Su, et al.
Disease Markers
|
May 13, 2022
Role of Cardiomyocyte-Derived Exosomal MicroRNA-146a-5p in Macrophage Polarization and Activation
Cong Chen, Sidong Cai, Min Wu, et al.
Frontiers in Pharmacology
|
January 11, 2021
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
Sidong Cai, Rong Liu, Panxia Wang, et al.
Acta Pharmaceutica Sinica. B
|
June 7, 2021
The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
Zhenzhen Li, Zhen Guo, Rui Lan, et al.
Journal of Pharmacological Sciences
|
April 21, 2016
PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy
Jingyan Li, Hui Gao, Junying Huang, et al.
Pharmacological Research
|
August 3, 2020
Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin
Sidong Cai, Panxia Wang, Tingting Xie, et al.
Diabetologia
|
February 27, 2024
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
Mengqi Su, Yilin Hou, Sidong Cai, et al.
Frontiers in Cell and Developmental Biology
|
October 29, 2020
Histone Demethylase JMJD3 Mediated Doxorubicin-Induced Cardiomyopathy by Suppressing SESN2 Expression
Panxia Wang, Rui Lan, Zhen Guo, et al.
Journal of Molecular and Cellular Cardiology
|
June 15, 2019
SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
Panxia Wang, Luping Wang, Jing Lu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Journal of Pharmacology
|
June 26, 2021
PEX5 prevents cardiomyocyte hypertrophy via suppressing the redox-sensitive signaling pathways MAPKs and STAT3
Minghui Wang, Jingyan Li, Yanqing Ding, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 11, 2023
miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway
Sidong Cai, Junlei Chang, Mengqi Su, et al.
Disease Markers
|
May 13, 2022
Role of Cardiomyocyte-Derived Exosomal MicroRNA-146a-5p in Macrophage Polarization and Activation
Cong Chen, Sidong Cai, Min Wu, et al.
Frontiers in Pharmacology
|
January 11, 2021
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
Sidong Cai, Rong Liu, Panxia Wang, et al.
Acta Pharmaceutica Sinica. B
|
June 7, 2021
The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
Zhenzhen Li, Zhen Guo, Rui Lan, et al.
Journal of Pharmacological Sciences
|
April 21, 2016
PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy
Jingyan Li, Hui Gao, Junying Huang, et al.
Pharmacological Research
|
August 3, 2020
Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin
Sidong Cai, Panxia Wang, Tingting Xie, et al.
Diabetologia
|
February 27, 2024
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
Mengqi Su, Yilin Hou, Sidong Cai, et al.
Frontiers in Cell and Developmental Biology
|
October 29, 2020
Histone Demethylase JMJD3 Mediated Doxorubicin-Induced Cardiomyopathy by Suppressing SESN2 Expression
Panxia Wang, Rui Lan, Zhen Guo, et al.
Journal of Molecular and Cellular Cardiology
|
June 15, 2019
SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
Panxia Wang, Luping Wang, Jing Lu, et al.
Page
of 2